Treatment of Familiar Lymphohistiocytosis

NCT02472054 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Hemophagocytic Lymphohistiocytosis (HLH)

Interventions

DRUG: Alemtuzumab
DRUG: Methyl Prednisolone (MP)
DRUG: Cyclosporin A (CSA)

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]